BridgeMD
New treatment option for HIS Bundle Pacing
Official title Ablate and Pace HIS Study
ClinicalTrials.gov ID: NCT06152406
What this study is testing
- What it's testing
- Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. Despite the advances in AF ablation strategies, the outcome of ablation procedures in persistent AF is still unsatisfactory.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Aged 18 or above
- Symptomatic AF, New York Heart Association (NYHA) class II-IV
- Willing to consent for the study
- AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following:
- Impaired LV function, EF \<50 %. And or
You likely can't join if
- Patient who has already got a pacemaker in situ
- Known severe LVSD when biventricular device is the thought to be the preferred pacing modality
- Females in child bearing period
- Lack of capacity to consent
- Other serious medical condition with life expectancy of less than 1 year
- Less than 18 years
See the full eligibility criteria
- Aged 18 or above
- Symptomatic AF, New York Heart Association (NYHA) class II-IV
- Willing to consent for the study
- AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following:
- Impaired LV function, EF \<50 %. And or
- Raised N-Terminal Pro B-type Natriuretic Peptide ( NT-ProBNP) \>365 ng/L
- Patient who has already got a pacemaker in situ
- Known severe LVSD when biventricular device is the thought to be the preferred pacing modality
- Females in child bearing period
- Lack of capacity to consent
- Other serious medical condition with life expectancy of less than 1 year
- Less than 18 years
- Unwilling to consent for the study
The study team makes the final eligibility decision.
Where it's taking place
- Leicester, Leicestershire, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leicester, Leicestershire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.